Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome

Kidney International

Volumn 62, Issue 3, 2002, Pages 868-876

  Liu, Hua ^a   Bigler, Steven A ^a   Henegar, Jeffrey R ^a   Baliga, Radhakrishna ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Catalytic iron; Glomerular injury; Heme oxygenase 1; Minimal change nephrotic syndrome; Puromycin aminonucleoside; Reactive oxygen metabolites

Indexed keywords

CIMETIDINE; CYTOCHROME P450 2B1; FERRITIN; HEME OXYGENASE; HYDROGEN PEROXIDE; IRON; PIPERINE; PUROMYCIN; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; GLOMERULUS BASEMENT MEMBRANE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEINURIA; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE; WESTERN BLOTTING;

EID: 0036419909     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00515.x     Document Type: Article

References (53)

1. Lannigan R, Kark R, Pollack VE: The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney: A light- and electron-microscope study. J Path Bact 83:357-362, 1962
2. Baliga R, Ueda N, Shah SV: Oxidant Mechanisms in Glomerular Disease, in Current Nephrology, edited by Gonick H, Chicago, Mosby Year Book, Inc., 1997, pp 135-151
3. Gonzalez FJ: The molecular biology of P450s. Pharmacol Rev 40:243-288, 1988
4. Kuthan H, Tsuji H, Graf H, et al: Generation of superoxide anion as a source of hydrogen peroxide in a reconstituted monooxygenase system. FEBS Lett 91:343-345, 1978
5. Nordblom GD, Coon MJ: Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch Biochem Biophys 180: 343-347, 1977
6. Gutteridge JM: Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201:291-295, 1986
7. Baliga R, Zhang Z, Baliga M, et al: Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 49:362-369, 1996
8. Baliga R, Zhang Z, Baliga M, et al: Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int 54:1562-1569, 1998
9. Bysani GK, Kennedy TP, Ky N, et al: Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J Clin Invest 86:1434-1441, 1990
10. Paller MS, Jacob HS: Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 91:7002-7006, 1994
11. Liu H, Shah SV, Baliga R: Cytochrome P450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. Am J Physiol 280:F88-F94, 2001
12. Dennery PA: Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 36:181-199, 2000
13. Ueda N, Baliga R, Shah SV: Role of "catalytic" iron in an animal model of minimal change nephrotic syndrome. Kidney Int 49:370-373, 1996
14. Dalvi RR, Dalvi PS: Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats. Drug Chem Toxicol 14:219-229, 1991
15. Reen RK, Wiebel FJ, Singh J: Piperine inhibits aflatoxin B1induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1. J Ethnopharmacol 58:165-173, 1997
16. Chang T, Levine M, Bellward GD: Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine. J Pharmacol Exp Ther 260:1450-1455, 1992
17. Rendic S, Kajfez F, Ruf HH: Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. Drug Metab Dispos 11:137-142, 1983
18. Baird MB, Sfeir GT, Slane-Pacini CD: Lack of inhibition of mouse catalase activity by cimetidine: An argument against a relevant general effect of cimetidine upon heme metabolic pathways. Biochem Pharmacol 36:4366-4369, 1987
19. Baliga R, Baliga M, Shah SV: Effect of selenium-deficient diet in experimental glomerular disease. Am J Physiol 263:F56-F61, 1992
20. Kutty RK, Nagineni CN, Kutty G, et al: Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol 159:371-378, 1994
21. Trakshel GM, kutty RK, Gaines MD: Purification and characterization of the major constitutive form of testicular heme oxygenase. The noninducible isoform. J Biol Chem 261:11131-11137, 1986
22. Gutteridge JM, Rowley DA, Halliwell B: Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem J 199:263-265, 1981
23. Gutteridge JM, Rowley DA, Halliwell B: Superoxide-dependent formation by hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochem J 206:605-609, 1982
24. Baliga R, Zhang Z, Baliga M, et al: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394-401, 1998
25. Burke MD, Thompson S, Elcombe CR, et al: Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345, 1985
26. Brand Sj, Dunn MJ: Analysis of membrane proteins by western blotting and enhanced chemiluminescence. Methods Mol Biol 19:211-218, 1993
27. Hsu SG, Raine L, Finger H: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734-738, 1981
28. Briggs RT, Drath DB, Karnovsky ML, et al: Localization of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J Cell Biol 67:566-586, 1975
29. Neale TJ, Ullrich R, Ojha P, et al: Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 90:3645-3649, 1993
30. Paschen W, Uto A, Djuricic B, et al: Hemeoxygenase expression after reversible ischemia of rat brain. Neurosci Lett 180:5-8, 1994
31. Nath KA, Balla G, Vercellotti GM, et al: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90:267-270, 1992
32. Agarwal A, Balla J, alam J, et al: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48:1298-1307, 1995
33. Balla G, Jacob HS, Balla J, et al: Ferritin: A cytoprotective antioxidant strategem of endothelium. J Biol Chem 267:18148-18153, 1992
34. Endou H, Koseki C, Hasumara S, et al: Renal cytochrome P-450: Its localisation along a single nephron and its induction, in Biochemistry of Kidney Functions, INSERM Symposium (No. 1), edited by Morel F, Amsterdam, Oxford, New York, Elsevier Biomedical Press BV, 1982, pp 319-327
35. Ogita K, Kusunose E, Yamamoto S, et al: Multiple forms of cytochrome P-450 from kidney cortex microsomes of rabbits treated with phenobarbital. Biochem Int 6:191-198, 1983
36. Ito O, Alonso-Galicia M, Hopp KA, et al: Localization of cytochrome P-450 4A isoforms along the rat nephron. Am J Physiol 274:F395-F404, 1998
37. Serron SC, Dwivedi N, Backes WE: Ethylbenzene induces microsomal oxygen free radical generation: Antibody-directed characterization of the responsible cytochrome P450 enzymes. Toxicol Appl Pharmacol 164:305-311, 2000
38. Kutty RK, Daniel RF, Ryan DE, et al: Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heine oxygenase. Arch Biochem Biophys 260:638-644, 1988
39. Hint DL, Jacobson HR: Functional effects of cytochrome P450 arachidonate metabolites in the kidney. Semin Nephrol 11:148-155, 1991
40. Carroll ma, balazy m, huang DD, et al: Cytochrome P450-derived renal HETEs: Storage and release. Kidney Int 51:1696-1702, 1997
41. Kappus H: Metabolic reactions: Role of cytochrome P450 in the formation of reactive oxygen species. Handb Exp Pharm 105:145-154, 1993
42. Karuzina II, Arcmucov AI: The oxidative inactivation of cytochrome P450 in monooxygenase reactions. Free Radic Biol Med 16:73-97, 1994
43. 2-forming NADPH oxidase of the phagocytes: Nature, mechanisms of activation and function. Biochim Biophys Acta 853:65-89, 1986
44. Halliwell B, Gutteridge JM: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85, 1990
45. Bissell DM, Hammaker LE: Cytochrome P-450 heme and the regulation of hepatic heme oxygenase activity. Arch Biochem Biophys 176:91-102, 1976
46. Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94:10925-10930, 1997
47. Nath KA, Haggard JJ, Croatf AJ, et al: The indispensability of heme oxygenase-1 in protecting against acute heme proteininduced toxicity in vivo. Am J Pathol 156:1527-1535, 2000
48. Shiraishi F, Curtis LM, Truong L, et al: Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol 278:F726-F736, 2000
49. Rizzardini M, Terao M, Falciani F, Cantoni L: Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J 290: 343-347, 1993
50. Cantoni L, Rossi C, Rizzardini M, et al: Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Biochem J279:891-894, 1991
51. Diamond JR, Pesek I: Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Lab Invest 64:21-28, 1991
52. Nakamura T, Ebihara I, Fukui M, et al: Altered glomerular steadystate levels of tumour necrosis factor-alpha mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats. Clin Sci 84:349-356, 1993
53. Alfrey AC, Froment DH, Hammond WS: A role of iron in tubulointerstitial injury in nephrotoxic serum nephritis. Kidney Int 36: 753-759, 1989